Stan Grof's Contributions to FDA Drug Development & Research with Psychedelics - Rick Doblin
Channel: MAPS
Date: 2015-01-20

MAPS Founder Rick Doblin, Ph.D., speaks about how Stanislav Grof's research influences MAPS' clinical studies focused on developing psychedelic-assisted psychotherapy into a prescription treatment.  This talk was filmed during the Expanding and Reenchanting the Psyche: The Pioneering Thought of Stanislav Grof conference at the California Institute of Integral Studies (CIIS) on October 24, 2014.

Filmed and edited by Chad Alexander

Help us caption and translate this video on Amara: http://bit.ly/1yH54fi